Description
| Strength | 2.5 g/ 0.5 g |
| Brand | Cefactive |
| Packaging Size | 1 Vial |
| Packaging Type | Box |
| Medicine Form | Injection Powder |
| Usage/Application | For Bacterial Infection |
| Manufacturer | Glenmark |
| Shelf Life | 24 months |
| Composition | Ceftazidime Avibactam |
| Minimum order quantity | 25 Piece |
Product’s Details:
- Cefactiv contains Ceftazidime, a third-generation cephalosporin antibiotic, combined with Avibactam, a non-β-lactam β-lactamase inhibitor. This combination broadens ceftazidime’s activity by shielding it from enzymatic breakdown caused by certain resistant bacteria.
- Side Effects: Common side effects may include:
- Headache
- Stomach pain
- Nausea or vomiting
- Diarrhea
- Rash or itching
Storage
- 2 °C to 8 °C (refrigerated) per standard refrigerating conditions
- Do not freeze
- Protect from Light
Indications
- Complicated intra-abdominal infections (cIAI) (used with metronidazole)
- Complicated urinary tract infections (cUTI) including pyelonephritis
- Hospital-acquired pneumonia (HAP) including ventilator-associated pneumonia (VAP)
- Infections due to multi-drug resistant Gram-negative organisms, including ESBL, KPC and AmpC-producing Enterobacteriaceae and Pseudomonas aeruginosa)
Reviews
There are no reviews yet.